Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFermi Inc Regulatory News (FRMI)

Share Price Information for Fermi Inc (FRMI)

Share Price is delayed by 15 minutes
Get Live Data
5.61    -0.57 (-9.22%)
Bid:
5.34
Ask:
5.88
Spread: 0.54 (10.112%)
Market Cap: $3.94b
FRMI Live PriceLast checked at - London Stock Exchange

Intraday Fermi Inc Share Chart

Form 8-K

30 Apr 2026 07:00

RNS Number : 5616C
Fermi Inc.
30 April 2026
 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) April 29, 2026

 

Fermi Inc.

(Exact name of registrant as specified in its charter)

 

Texas

001-42888

33-3560468

(State or other jurisdictionof incorporation)

(Commission File Number)

(IRS EmployerIdentification No.)

 

620 S. Taylor St., Suite 301Amarillo, TX

79101

(Address of principal executive offices)

(Zip Code)

 

Registrant's telephone number, including area code: (214) 894-7855

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.001 par value

FRMI

The Nasdaq Stock Market LLC

Common Stock, $0.001 par value

FRMI

The London Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Appointment of Interim Chief Financial Officer

 

On April 29, 2026, the Board of Directors (the "Board") of Fermi Inc. (the "Company) appointed Robert L. Masson as Interim Chief Financial Officer ("Interim CFO") and the principal financial officer of the Company effective April 29, 2026, until a permanent successor is named.

 

Mr. Masson, age 55, brings over 20 years of experience as a finance executive in the aerospace, defense, and industrial sectors. Mr. Masson was the Chief Financial Officer of Noble Supply and Logistics, LLC ("Noble") from 2023 through 2025. Before joining Noble, he served as Chief Financial Officer of Latham Group, Inc. from 2022 to 2023. Mr. Masson also served as Executive Vice President and Chief Financial Officer of Hypertherm, Inc. from 2018 through 2022, where he oversaw the company's global financial, information technology, and legal operations. From 2016-2018, Mr. Masson was Vice President of Finance at Flowserve, where he led the company's operational finance, operational accounting, and corporate financial planning and analysis teams. From 2003-2016, he served in various finance leadership roles at Raytheon Technologies, including Chief Financial Officer roles for several of the company's business units. Mr. Masson began his career as a Lieutenant and Naval Aviator for the United States Navy, where he worked from 1992-2001. Mr. Masson holds a Bachelor of Science degree in Economics from the United States Naval Academy and a Master of Business Administration from Harvard Business School.

 

The Board has not approved any compensation for Mr. Masson in connection with his appointment as Interim CFO. If and when the Company enters into any material compensatory arrangement with Mr. Masson in connection with his appointment, the Company will file an amendment to this Current Report on Form 8-K to disclose the material terms thereof, as required by Item 5.02(e) of Form 8-K.

 

There are no arrangements or understandings between Mr. Masson and any other person pursuant to which Mr. Mason was appointed as Interim CFO of the Company. Mr. Masson does not have a family relationship with any director or executive officer of the Company (or any person nominated or chosen by the Company to become a director or executive officer of the Company) or a direct or indirect material interest in any existing or currently proposed transaction that would require disclosure under Item 404(a) of Regulation S-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.

Description

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements that involve substantial risks and uncertainties. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Section 27A of the Securities Act of 1933, as amended (the "Securities Act"). In some cases, you can identify forward-looking statements by the words "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "foreseeable," "future," "intend," "may," "might," "objective," "ongoing," "plan," "potential," "predict," "project," "seek," "should," "will," or "would" and/or the negative of these terms, or other comparable terminology intended to identify statements about the future. They may include statements regarding our intentions, beliefs or current expectations concerning, among other things, the Company's potential customer pipeline and expected power demand and delivery. Forward-looking statements are inherently subject to risks, uncertainties and assumptions that are difficult to predict or quantify, including those risks described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 and our other filings with the SEC. Forward-looking statements speak only as of the date of this Current Report on Form 8-K. We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

FERMI INC.

Date: April 29, 2026

By:

/s/ George Wentz

Name: 

George Wentz

Title:

General Counsel

 

2

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCWPUCACUPQUAU
Date   Source Headline
18th May 20261:30 pmRNSPreliminary Consent Revocation Statement
15th May 20266:34 pmRNS1st Quarter Results
14th May 202612:00 pmRNS1st Quarter Results
14th May 20268:00 amRNSForm 8-K
11th May 20267:00 amRNSFirst Quarter 2026 Earnings Release & Call Date
6th May 20267:49 amRNSFermi Proxy Response Press Release
6th May 20267:48 amRNSForm 8-K
5th May 20267:06 amRNSForm 8-K
1st May 20267:00 amRNSForm 8-K/A
30th Apr 20267:00 amRNSInterim CFO Appointment
30th Apr 20267:00 amRNSForm 8-K
20th Apr 20267:08 amRNSFermi Inc. announcement
20th Apr 20267:08 amRNSFORM 8-K
1st Apr 202612:05 pmRNSFermi Secures $156.25m Financing from Yorkville
31st Mar 20267:00 amRNSAnnual Report - Form 10-K
30th Mar 202612:14 pmRNSShareholder Letter FY 2025
30th Mar 202612:00 pmRNSFY 2025 Earnings & Investor Call
30th Mar 202611:00 amRNSForm 8-K - Current Report
30th Mar 20267:00 amRNSFermi Files Second Clean Air Permit Application
27th Mar 202611:00 amRNSFermi Secures $165m Equipment Financing Facility
11th Mar 202611:27 amRNS-RFermi CNO Addresses NRC Conference 2026
26th Feb 20267:00 amRNSFermi America Secures Final 6GW Clean Air Permit
25th Feb 20267:00 amRNSFermi America Announces Q4 2025 Earnings Call
20th Feb 20267:00 amRNSInitial Draw on $200m Equipment Facility
12th Feb 20267:09 amRNS-RFermi America Deepens Partnership with Hyundai E&C
11th Feb 20267:00 amRNSMUFG Backs Fermi America with $500 Million Loan
11th Feb 20267:00 amRNSCurrent Report on Form 8-K
9th Feb 202612:00 pmRNS-RArrival of 6 Siemens Energy SGT-800 Gas Turbines
30th Jan 20267:00 amRNSAdmission of Over-allotment and Additional Shares
28th Jan 202612:00 pmRNSAdmission of Over-allotment and Additional Shares
12th Dec 20257:00 amRNSUpdate on AICA
8th Dec 20257:00 amRNSElectric agreement with Xcel Energy
1st Dec 202512:00 pmRNSFermi and MVM EGI Announce Hybrid Cooling MOU
25th Nov 20257:00 amRNSResponse to Speculation
13th Nov 20257:00 amRNSPublication of Fermi Inc. Interim Financial Report
11th Nov 20257:00 amRNSFermi Posts Third Quarter 2025 Shareholder Letter
6th Nov 20257:00 amRNSAdvance in Aid of Construction Agreement
5th Nov 20257:00 amRNSNotice of Inaugural Earnings Call
4th Nov 20257:00 amRNSState of Texas Preliminary Approval for First 6GW
30th Oct 20257:00 amRNSPartnerships Announcement
29th Oct 20251:33 pmRNSPartnerships Announcement
27th Oct 20257:00 amRNSContract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.